- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07540429
ADOLESCENTS IMAGING USING fMRI: Feasibility Study (ADO IMAGE)
April 17, 2026 updated by: Etablissement Public de la Sante Mentale de la Somme
Feasibility Study Using Functional Magnetic Resonance Imaging (fMRI) on Bordeline Personality Disorders in Adolescents
Impaired social cognition and cognitive control associated with borderline personality disorder (BPD) remain less explored.
Recent Franco-Canadian study, has shown the feasibility of a neuroimaging tests in Quebec adolescents with BPD.
This study aims to increase knowledgements related to neural correlates of BPD and clinical disorders.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: MICHAEL MONET, PhD
- Phone Number: 0322534612
- Email: unite.2.recherche@epsm-somme.fr
Study Contact Backup
- Name: Jean Marc GUILE, Professor
- Email: jmguile@gmail.com
Study Locations
-
-
-
Dury, France, 80480
- Recruiting
- EPSM de la Somme
-
Contact:
- MICHAEL MONET
- Phone Number: 0322534612
- Email: unite.2.recherche@epsm-somme.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Female adolescents meeting DIB-R criteria for BPD group
- Female adolescents meeting kSADS-PL for ADHD group
- Female adolescents without any psychologic disorders
Exclusion Criteria:
- Any medical history with head trauma, chronic neurologic disease, any contraindications for fRMI, claustrophobia or pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Healthy adolescent girl volunteers
The participants will follow the same study plan
|
Investigators used fMRI to compare patterns of regional brain activation between three groups of adolescents girls: Six female adolescents meeting criteria for BPD, 6 female adolescents meeting criteria of ADHD and 6 female adolescents without psychiatric disorder were recruited.
|
|
Other: Adolescent girls with borderline personality disorder
The participants will follow the same study plan
|
Investigators used fMRI to compare patterns of regional brain activation between three groups of adolescents girls: Six female adolescents meeting criteria for BPD, 6 female adolescents meeting criteria of ADHD and 6 female adolescents without psychiatric disorder were recruited.
|
|
Other: Adolescent girls with Attention Deficit Hyperactivity Disorder
The participants will follow the same study plan
|
Investigators used fMRI to compare patterns of regional brain activation between three groups of adolescents girls: Six female adolescents meeting criteria for BPD, 6 female adolescents meeting criteria of ADHD and 6 female adolescents without psychiatric disorder were recruited.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MRI-Acquired Activation Mapping
Time Frame: 2 years
|
Establishment of activation maps by statistical analysis of local signal variations to locate functional regions essential to motor skills and language.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of this study
Time Frame: 2 years
|
Pilot feasibility study with a small sample size
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jean Marc GUILE, Professor, EPSM de la Somme
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 8, 2024
Primary Completion (Estimated)
June 8, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
February 18, 2026
First Submitted That Met QC Criteria
April 17, 2026
First Posted (Actual)
April 20, 2026
Study Record Updates
Last Update Posted (Actual)
April 20, 2026
Last Update Submitted That Met QC Criteria
April 17, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-A00741-42
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on functional magnetic resonance imaging (fMRI)
-
University Hospital, GrenobleCompleted
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Hospices Civils de LyonNot yet recruiting
-
University of MichiganCompletedHealthy ParticipantsUnited States
-
Massachusetts General HospitalBrain & Behavior Research FoundationCompletedBipolar Disorder | Major Depression | RuminationUnited States
-
Lykos TherapeuticsCompleted
-
Maastricht University Medical CenterTerminatedChronic Obstructive Pulmonary Disease | Pancreatic Cancer | Cachexia | Non-small Cell Lung CancerNetherlands
-
University of California, IrvineWithdrawnMild Traumatic Brain InjuryUnited States
-
University Hospital, ToulouseCompleted